Theoretical dissolution model of poly-disperse drug particles in biorelevant media.
暂无分享,去创建一个
[1] M. Kozlov,et al. Phase boundaries in mixtures of membrane-forming amphiphiles and micelle-forming amphiphiles. , 2000, Biochimica et biophysica acta.
[2] Y. Masaoka,et al. Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system. , 2006, Journal of pharmaceutical sciences.
[3] J. Delaney. Predicting aqueous solubility from structure. , 2005, Drug discovery today.
[4] E. Kerns,et al. High throughput physicochemical profiling for drug discovery. , 2001, Journal of pharmaceutical sciences.
[5] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[6] Martin Kuentz,et al. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] T. Nagai,et al. Prediction of available surface area of powdered particles of flufenamic acid in tablets. , 1985, Chemical & pharmaceutical bulletin.
[8] Kiyohiko Sugano,et al. High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.
[9] Thierry Lavé,et al. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] J. Dressman,et al. Comparison of the Mechanism of Dissolution of Hydrocortisone in Simple and Mixed Micelle Systems , 1993, Pharmaceutical Research.
[11] Christos Reppas,et al. Biorelevant Dissolution Testing to Predict the Plasma Profile of Lipophilic Drugs After Oral Administration , 2001, Pharmaceutical Research.
[12] Panos Macheras,et al. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.
[13] Anette Müllertz,et al. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[15] C. Larive,et al. A mechanistic study of danazol dissolution in ionic surfactant solutions. , 2003, Journal of pharmaceutical sciences.
[16] H. Kristensen,et al. Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. , 2006, Journal of pharmaceutical sciences.
[17] Kiyohiko Sugano,et al. Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test , 2006, Pharmaceutical Research.
[18] C. Larive,et al. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions. , 1997, Journal of pharmaceutical sciences.
[19] N. Kaniwa,et al. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets. , 1982, Journal of pharmacobio-dynamics.
[20] R. J. Hintz,et al. The effect of particle size distribution on dissolution rate and oral absorption , 1989 .
[21] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[22] J. Legendre,et al. Determination of the Aqueous Solubility of Drugs Using a Convenient 96-Well Plate-Based Assay , 2001, Drug development and industrial pharmacy.
[23] Kouki Obata,et al. Processing of Biopharmaceutical Profiling Data in Drug Discovery , 2007 .
[24] C. Bevan,et al. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.
[25] W. Nernst,et al. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[26] Anand Balakrishnan,et al. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. , 2004, Journal of pharmaceutical sciences.
[27] M. Machida,et al. Biopharmaceutics Classification by High Throughput Solubility Assay and PAMPA , 2004, Drug development and industrial pharmacy.
[28] P. Harriott. Mass transfer to particles: Part I. Suspended in agitated tanks , 1962 .
[29] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[30] T. Nagai,et al. Effect of compression pressure and formulation on the available surface area of flufenamic acid in tablets. , 1986, Chemical & pharmaceutical bulletin.
[31] T. Nagai,et al. Dissolution profiles of nalidixic acid powders having Weibull particle size distribution. , 1985, Chemical and pharmaceutical bulletin.
[32] M. Odomi,et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[33] Vinod P. Shah,et al. Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.
[34] Alex Avdeef,et al. Physicochemical Profiling (Solubility, Permeability and Charge State) , 2001 .
[35] M. Rogge,et al. Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability , 1993, Journal of clinical pharmacology.
[36] A. Glomme,et al. Predicting the Intestinal Solubility of Poorly Soluble Drugs , 2007 .
[37] Christos Reppas,et al. Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data , 1999, Pharmaceutical Research.
[38] S Chakrabarti,et al. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 1. Effect of tablet geometry in buffered medium. , 1996, Journal of pharmaceutical sciences.
[39] Kevin C. Johnson,et al. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.
[40] S Chakrabarti,et al. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers. , 1997, Journal of pharmaceutical sciences.